These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30810811)

  • 21. TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression.
    Garcia-Montojo M; Fathi S; Rastegar C; Simula ER; Doucet-O'Hare T; Cheng YHH; Abrams RPM; Pasternack N; Malik N; Bachani M; Disanza B; Maric D; Lee MH; Wang H; Santamaria U; Li W; Sampson K; Lorenzo JR; Sanchez IE; Mezghrani A; Li Y; Sechi LA; Pineda S; Heiman M; Kellis M; Steiner J; Nath A
    Nat Commun; 2024 May; 15(1):4163. PubMed ID: 38755145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of TDP-43 mediates severe neurotoxicity by suppressing PJA1 gene transcription in the monkey brain.
    Zhu L; Deng F; Bai D; Hou J; Jia Q; Zhang C; Ou K; Li S; Li XJ; Yin P
    Cell Mol Life Sci; 2024 Jan; 81(1):16. PubMed ID: 38194085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution.
    Maraschi A; Gumina V; Dragotto J; Colombrita C; Mompeán M; Buratti E; Silani V; Feligioni M; Ratti A
    Mol Neurobiol; 2021 Nov; 58(11):5682-5702. PubMed ID: 34390468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal regenerative responses and impaired axonal outgrowth after nerve crush in TDP-43 transgenic mouse models of amyotrophic lateral sclerosis.
    Swarup V; Audet JN; Phaneuf D; Kriz J; Julien JP
    J Neurosci; 2012 Dec; 32(50):18186-95. PubMed ID: 23238732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
    Ratti A; Buratti E
    J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination.
    Dammer EB; Fallini C; Gozal YM; Duong DM; Rossoll W; Xu P; Lah JJ; Levey AI; Peng J; Bassell GJ; Seyfried NT
    PLoS One; 2012; 7(6):e38658. PubMed ID: 22761693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy.
    Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE
    Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
    Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.
    Barmada SJ; Skibinski G; Korb E; Rao EJ; Wu JY; Finkbeiner S
    J Neurosci; 2010 Jan; 30(2):639-49. PubMed ID: 20071528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.
    Janssens J; Van Broeckhoven C
    Hum Mol Genet; 2013 Oct; 22(R1):R77-87. PubMed ID: 23900071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice.
    Xu YF; Zhang YJ; Lin WL; Cao X; Stetler C; Dickson DW; Lewis J; Petrucelli L
    Mol Neurodegener; 2011 Oct; 6():73. PubMed ID: 22029574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
    Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
    J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
    Gordon D; Dafinca R; Scaber J; Alegre-Abarrategui J; Farrimond L; Scott C; Biggs D; Kent L; Oliver PL; Davies B; Ansorge O; Wade-Martins R; Talbot K
    Neurobiol Dis; 2019 Jan; 121():148-162. PubMed ID: 30290270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.
    Cohen TJ; Lee VM; Trojanowski JQ
    Trends Mol Med; 2011 Nov; 17(11):659-67. PubMed ID: 21783422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant.
    Wobst HJ; Delsing L; Brandon NJ; Moss SJ
    PLoS One; 2017; 12(5):e0177181. PubMed ID: 28510586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43.
    Caccamo A; Majumder S; Oddo S
    Am J Pathol; 2012 Jan; 180(1):293-302. PubMed ID: 22067910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy.
    Ihara R; Matsukawa K; Nagata Y; Kunugi H; Tsuji S; Chihara T; Kuranaga E; Miura M; Wakabayashi T; Hashimoto T; Iwatsubo T
    Hum Mol Genet; 2013 Nov; 22(22):4474-84. PubMed ID: 23804749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons.
    Nagano S; Jinno J; Abdelhamid RF; Jin Y; Shibata M; Watanabe S; Hirokawa S; Nishizawa M; Sakimura K; Onodera O; Okada H; Okada T; Saito Y; Takahashi-Fujigasaki J; Murayama S; Wakatsuki S; Mochizuki H; Araki T
    Acta Neuropathol; 2020 Nov; 140(5):695-713. PubMed ID: 32803350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.
    Nishimoto Y; Ito D; Yagi T; Nihei Y; Tsunoda Y; Suzuki N
    J Biol Chem; 2010 Jan; 285(1):608-19. PubMed ID: 19887443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy.
    Liachko NF; Guthrie CR; Kraemer BC
    J Neurosci; 2010 Dec; 30(48):16208-19. PubMed ID: 21123567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.